2 3 m a r c h 2 0 1 7 | V O L 5 4 3 | N a T U r E | 5 0 7 arTicLE Diverse genetic defects, immunological insults, and certain epilepsies have been implicated in the pathophysiology of autism spectrum disorder (ASD) 1,2 . These varied aetiologies may converge to disrupt specific molecular interactions in specialized neuronal subtypes to produce autism's sociability deficits. A common and highly penetrant genetic ASD results from maternally inherited 15q11-13 triplications 3,4 that triple the neuron-expressed gene dosage of UBE3A, which is deleted in Angelman syndrome 5-8 . UBE3A encodes a dual-function E3 ubiquitin ligase 9 and transcriptional co-regulator 10 . We previously demonstrated that mice with increased genomic Ube3a copies (termed 'Ube3a-2×' mice) display impaired sociability, diminished conspecific ultrasonic vocalizations and heightened repetitive self-grooming, together with deficits in cortical excitatory transmission 4 . However, the subcellular locus, downstream molecular mechanisms and circuit deficits responsible for the effect of UBE3A on sociability remain unknown.
UBE3A effects map to the nucleus
To address these questions, we first examined the altered cortical transcriptional landscape in Ube3a-2× mice that display a roughly threefold increase in total UBE3A protein 4, 11 . On an Affymetrix microarray analysis of total RNA from whole cortex of adult Ube3a-2× and wildtype littermate mice, we identified 190 up-and 408 downregulated genes (P < 0.05 false discovery rate (FDR)-adjusted, ±1.4-fold cutoff; Supplementary Table 1 ) enriched for glutamatergic synaptic transmission function ( Supplementary Table 2 ). To understand how these genes interact with known ASD genes, we visualized ( Fig. 1a , Extended Data Fig. 1 ) how their encoded proteins are positioned within a network of protein-protein physical interactions with 276 genes strongly implicated in autism 12 (Supplementary Table 3 ). As a candidate downstream mediator of the effects of UBE3A, we focused on CBLN1 because it was dose-dependently repressed by UBE3A and binds presynaptic NRXN1/2/3 and postsynaptic GRID1/2 (refs 13-17) , two gene families deleted or mutated in ASD 3, 12 . Trimolecular complexes of NRXN-CBLN1-GRID trans-synaptically organize glutamatergic synapse formation [16] [17] [18] [19] . Cbln1 also compensates for congenital losses of Cbln3 (ref. 20) . Using quantitative PCR with reverse transcription (qRT-PCR), we found downregulated Cbln1 in cortical samples from Ube3a-1× and Ube3a-2× mice (heterozygous and homozygous for a C-terminal Flag-tagged Ube3a transgene 4 , respectively). Cbln1 was also repressed in 'Ube3a-NLS' mice (heterozygous for a Flag-tagged UBE3A confined to the nucleus with two nuclear localization signals (NLS); Extended Data Fig. 2a-d ) and in Ube3a-2× (untagged) mice (homozygous for an untagged Ube3a gene) ( Fig. 1b ). Cortical Cbln1 expression was increased in hemizygous maternal knockout Ube3a mice (Ube3a-mKO; modelling Angelman syndrome) 5 , whether the deleted Ube3a allele was inherited from an asymptomatic mother (paternally deleted allele, 'p-Ube3a-mKO') or an affected mother (maternally deleted allele, 'm-Ube3a-mKO') 21 . Several UBE3A-downregulated genes displayed dose-dependent and nuclear-mediated effects (Fig. 1c , Extended Data Fig. 3 ), a finding less consistent for UBE3A-upregulated genes (Extended Data Fig. 4 ).
Transgenic increases of Ube3a also had an effect on conspecific social behaviour in a dose-dependent manner (irrespective of the presence of the C-terminal tag). However, this dose dependence was overcome by targeting UBE3A to the nucleus. In the three-chamber sociability task 22 (see Methods), Ube3a-2× mice 4 as well as Ube3a-2× (untagged) mice displayed impaired sociability ( Fig. 1d , Extended Data Fig. 2e, f) . Two independent Ube3a-NLS lines (lines 3 and 7) also displayed impaired sociability. By contrast, sociability was not repressed in Ube3a-1× (with twice the normal amounts of UBE3A protein) or Ube3a-mKO mice. Ube3a-2× (tagged and untagged) and Ube3a-NLS mice also emitted fewer ultrasonic vocalizations (USVs) ( Fig. 1e ) and displayed fewer physical interactions when exposed to genotype-matched strangers (Extended Data Fig. 2g ). These social phenotypes could not be explained by changes in grooming, olfaction, exploration or locomotion (Extended Data Fig. 2h-m) . Therefore, an otherwise asymptomatic increase of UBE3A (Extended Data Fig. 2a ), when confined to the nucleus (in Ube3a-NLS mice), recapitulates the transcriptional downregulations and impaired sociability seen in Ube3a-2× mice.
To connect decreased Cbln1 expression directly to impaired sociability, we deleted Cbln1 in glutamatergic vesicular glutamate transporter 2 (VGLUT2 + ) neurons. VGLUT2-cre;Cbln1 fl/fl (VGLUT2 is also known as Slc17a6) mice had reduced Cbln1 expression across several brain regions (Fig. 1f, Extended Data Fig. 5a ), impaired sociability ( Fig. 1g, Extended Data Fig. 5b,c) , and fewer USVs and physical interactions with stranger females (Fig. 1h, Extended Data Fig. 5d ).
Grooming, exploration, locomotion and olfaction were unaffected, although rotarod performance was mildly impaired (Extended Data Fig. 5e-k) . Thus, deleting Cbln1 in VGLUT2-cre-labelled neurons reconstitutes the social deficits of Ube3a-2× (tagged or untagged) and Ube3a-NLS mice. Together with the reported sociability impairments in homozygous Grid1-knockout mice 23 , these results implicate glutamate synapses dependent on CBLN1 and GRID1 in promoting normal sociability.
Seizure-induced deficits are UBE3A-dependent
Cbln1 mRNA is also repressed by increased neuronal activity in the cerebellum in culture after depolarization and in vivo after status epilepticus 24 . Therefore, we tested whether recurrent seizures can concurrently repress Cbln1 and sociability. We exposed wild-type mice to Δ Cbln1 mRNA over 
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Figure 1 | Nuclear-targeted increases of UBE3A repress ASD network gene
Cbln1 that is required in VGLUT2 + neurons for sociability. a, Protein interaction sub-cluster enriched for glutamatergic synapse proteins encoded by autism-linked 13 ECx, entorhinal cortex; HPc, hippocampus; MA, medial amygdala; RSCx, retrosplenial cortex; VMH, ventromedial hypothalamus; VTA, ventral tegmental area. g, h, Sociability (Cre − n = 8, Cre + n = 10) (g) and USVs in male-female (Cre − n = 14, Cre + n = 8) and genotype-matched femalefemale (Cre − n = 11, Cre + n = 16) pairs (h). Data are mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001. NS, not significant. Unpaired twotailed Student's t-test was used for comparisons across two groups (for example, panel e). For three-chamber experiments, sniffing time was analysed by two-way repeated-measures analysis of variance (ANOVA). F statistics and P values for 'interaction effects' between chamber side (social versus opposite) or experimental group (viruses, treatments or genotypes) and 'main effects' are shown in Supplementary Table 5 . For significant interaction and/or main effects, a Bonferroni post-hoc test P value is reported (adjusted for multiple comparisons). 10 successive daily injections of GABA A receptor antagonist pentylenetetrazole (PTZ) at subconvulsant doses (30 mg kg −1 ), and observed a gradual increase in seizure severity ( Fig. 2a , left, Extended Data Fig. 6a, b ). After 24 h, Cbln1 mRNA was repressed in several brain regions ( Fig. 2a , right), sociability was impaired 25 and social USVs were reduced ( Fig. 2b , c) without impacting exploration, locomotion, grooming or olfaction (Extended Data Fig. 6c -k). This sociability deficit persisted for 30 days (Extended Data Fig. 6l , m). To examine how the dosage of Ube3a might affect seizure-induced social impairments, we applied 10 PTZ-induced seizures to p-Ube3a-mKO, m-Ube3a-mKO and their corresponding wild-type littermates. Seizure severities were similar, but both Ube3a-mKO mice were resistant to seizure-induced deficits in sociability ( Fig. 2d -g, Extended Data Fig. 6n ). Conversely, to test whether 'asymptomatic' increases of UBE3A augment seizureinduced sociability deficits, we applied a subthreshold PTZ model to Ube3a-1× (untagged) mice in which five 30 mg kg −1 PTZ injections are delivered every other day. After 24 h, Ube3a-1× (untagged) mice displayed impaired sociability whereas wild-type littermates were unaffected ( Fig. 2h -j, Extended Data Fig. 6o , p). Seizure effects were not explained by changes in Ube3a mRNA (Extended Data Fig. 6q ). Overall, these results demonstrate that UBE3A is necessary for seizure-induced decreases in sociability and Cbln1 expression, and illustrate an Ube3a-seizure synergy in promoting impaired sociability.
UBE3A-seizure synergy maps to VTA
To identify the neuronal circuits underlying this synergy, we engineered our full-length UBE3A-Flag construct 4 with a loxP-flanked transcriptional/ translational blocker (TB) cassette in intron 1. In these 'lox-TB-Ube3a' transgenic mice, cell-type-specific Cre expression deletes the TB cassette to activate UBE3A-Flag expression and moderately increase total Ube3a mRNA ( Fig. 3a , b, f, Extended Data Fig. 7a -h). Baseline sociability was not impaired in mice with UBE3A-Flag expression targeted by VGLUT2-cre, VGAT-cre (also known as Slc32a1-cre), Emx-cre, Math1-cre (Atoh1-cre), DAT-cre (Slc6a3-cre), Dbh-cre, Chat-cre or ePet-cre driver lines ( Fig. 3c , g, Extended Data Figs 7c-h, 8). However, sociability deficits were produced by the subthreshold PTZ model in mice with UBE3A-Flag increased in VGLUT2 or DAT (dopamine transporter)-expressing neurons ( Fig. 3d , e, h, i, Extended Data Fig. 8 ). DAT + and VGLUT2 + neurons co-exist in the VTA, alongside GABAergic and glutamate/dopamine co-releasing neurons 26, 27 . Optogenetic modulation of VTA dopaminergic projections to the nucleus accumbens (NAc) alters social approach behaviour in mice 28 . VTA VGLUT2 + neurons are situated in the medial VTA 29 and project to several regions including the NAc 26 , but have not been ascribed a role in social behaviour. After 10 daily recurrent PTZinduced seizures, VTA Cbln1 mRNA levels were increased in Ube3a-mKO mice and repressed in Ube3a-1× (untagged) mice ( Fig. 2k , with similar results obtained in Ube3a-1× mice 4 , Extended Data Fig. 9a ). Thus, changes in VTA Cbln1 expression parallel the relative resistance of Ube3a-mKO and vulnerability of Ube3a-1× (tagged or untagged) mice to seizure-induced sociability deficits.
To increase untagged UBE3A selectively in VTA VGLUT2 + neurons, we injected the VTA of VGLUT2-cre and wild-type littermate mice with the adeno-associated virus AAV-hSYN-DIO-UBE3A (human isoform 3, enabling Cre-recombinase-mediated expression of untagged UBE3A; Fig. 3j ). Sociability was preserved at baseline, but impaired by the subthreshold PTZ model ( Fig. 3k -m, Extended Data Fig. 9b, c) . Cre -(12) Cre + (9) Cre -(13) Cre + (16) Cre -(8) Cre + (10) Thus, increasing UBE3A selectively in VTA VGLUT2 + neurons synergizes with seizures to impair sociability.
Midbrain VTA-targeted deletion of Cbln1
To link VTA Cbln1 mRNA downregulations to sociability deficits, we infused AAV-Cre-GFP (or AAV-GFP) into the VTA of Cbln1 fl/fl mice. After 20 days, Cre-injected mice displayed impaired sociability without changes in locomotion or exploration ( Fig. 4a , Extended Data Fig. 9d-f ). Similarly, mice with VGLUT2 neuron-targeted deletions of Cbln1 in the VTA displayed impaired sociability (AAV-encoded Cre-RFP or RFP (red fluorescent protein, mCherry) alone driven by the VGLUT2 promoter, 28 days later; Fig. 4b , Extended Data Fig. 9g ). These effects were cell-type-specific in the VTA: Cbln1 deletions restricted to DAT + neurons did not impair sociability ( Fig. 4c , Extended Data Fig.  9h ). Given the role of Cbln1 in the integrity of cerebellar glutamatergic synapses 14, 28 , we tested whether Cbln1 deletions in the VTA or recurrent seizures impair glutamatergic transmission. We deleted VTA Cbln1 by injecting AAV-Cre-GFP into the VTA of Cbln1 fl/fl mice containing a Cre-inducible form of a light-activated excitatory opsin (channelorhodopsin-2 (ChR2); ChR2-eYFP or ' Ai32' mice), enabling light-induced excitation of axon terminals in VTA targets ( Fig. 4d ). After 6 weeks, patch-clamp recordings from medium spiny neurons (MSNs) in the NAc medial shell (a VTA glutamatergic neuron target 26 ), with GABA A receptor antagonist bicuculline present revealed that VTA Cbln1 deletion or 10 PTZ-induced seizures strongly reduces light-evoked excitatory postsynaptic currents (EPSCs; Fig. 4e , Extended Data Fig. 9i -l). The frequency of spontaneous EPSCs in NAc medial shell MSNs was also decreased ( Fig. 4f , Extended Data Fig. 9i ). To examine glutamatergic transmission specifically from VTA VGLUT2 + neurons, we injected AAV-DIO-ChR2-eYFP into the VTA of VGLUT2cre;Cbln1 fl/fl and VGLUT2-cre mice. After 30 days, VGLUT2-specific Cbln1 deletion also repressed these light-evoked EPSCs in the NAc (Fig. 4g, h ).
VTA glutamate neurons drive sociability
These results suggested that reducing VTA glutamatergic transmission might itself impair sociability. We selectively deleted VGLUT2 in the VTA by injecting AAV-Cre-GFP (or AAV-GFP) into VGLUT2 fl/fl mice. After 20 days, VTA-targeted VGLUT2 deletions impaired sociability without affecting locomotion or exploration ( Fig. 4i , Extended Data Fig. 9m -o). Again, these effects were cell-type-specific: VGLUT2 deletion in DAT + neurons did not impair sociability ( Fig. 4j , Extended Data Fig. 9p ). Thus, a viral-mediated or seizure-induced loss of Cbln1 in VTA VGLUT2 + neurons impairs VTA glutamatergic synaptic transmission that is necessary for normal sociability.
To interrogate how acutely regulating VTA VGLUT2 + neuron activity affects sociability, we applied chemogenetic approaches. VGLUT2-cre mice received VTA injections of AAV-DIO-HA-KORD-IRES-citrine, permitting Cre-dependent expression of an inhibitory G i -coupled designer receptor activated by salvinorin-B. After 28 days, subcutaneous administration of salvinorin-B acutely repressed sociability ( Fig. 5a , Extended Data Fig. 10a ). Conversely, to increase VTA VGLUT2 + neuron activity acutely, VGLUT2-cre mice were injected with AAV-DIO-hM3D(G q )-mCherry in the VTA, enabling the expression of an excitatory G q -coupled designer receptor activated by clozapine-N-oxide (CNO). After 28 days, intraperitoneal CNO administration acutely increased sociability in seizure-naive mice (persisting through a second 5-min of a social trial; Fig. 5b , Extended Data Fig. 10b ).
Rescuing sociability deficits
Acute chemogenetic activation of VTA VGLUT2 + neurons also therapeutically restored sociability in mice with deficits produced by the Ube3a-seizure synergy or by 10 PTZ-induced seizures ( Fig. 5c, d , Extended Data Fig. 10c, d ). VGLUT2-cre mice were coinjected with AAV-hSYN-DIO-UBE3A and either AAV-DIO-GFP or AAV-hSYN-DIO-CBLN1-IRES-RFP. Increased Cbln1 expression in VTA VGLUT2 + neurons did not affect baseline social behaviour or seizure severity scores, but did protect against the sociability deficits produced by the UBE3A-seizure synergy ( Fig. 5e -g, Extended Data Fig. 10e ). These results indicate that diminished Cbln1 expression in VTA VGLUT2 + neurons has a crucial pathogenic role in mediating the effects of seizures and increased Ube3a on sociability.
Discussion
Our results suggest that the UBE3A increases found in patients with 15q11-13 ASD 11 may repress CBLN1 expression to disrupt NRXN-CBLN1-GRID1 complexes and compromise glutamatergic synaptic transmission. This mechanism may also contribute to social impairments in patients with biologically related genetic defects (for example, GRID1 or NRXN1 deletions) and other patients with ASD and comorbid seizures 2 . We show that neuronal UBE3A is necessary for seizure-induced Cbln1 repression, potentially functioning as a transducer of pathological activity-induced changes in gene expression 30 . UBE3A may repress Cbln1 through its transcriptional co-regulatory functions 10,31,32 . For example, UBE3A physically interacts with methyl CpG-binding protein 2 (MECP2; deleted in Rett syndrome) 33 that represses a subset of genes through interactions with the nuclear receptor co-repressor complex 34 . Seizures upregulate RE-1 silencing transcription factor (REST) in the hippocampus 35, 36 as well as in the VTA (Extended Data Fig. 10f ), and Cbln1 intron 2 contains a consensus RE-1 that binds the REST transcriptional repressor 37 (Extended Data Fig. 10g ). Seizures may also enhance the transcriptional modulatory functions of UBE3A by dephosphorylating Thr480 (Thr485 in humans) to promote its nuclear translocation 38 . Indeed, our behavioural and molecular findings in Ube3a-NLS mice support such a model. With native UBE3A still present and the potential to homomultimerize 39 , our experimental approach does not exclude a role of the UBE3A E3-ligase functions 9, 38, 40 . Increased UBE3A was found to amplify the detrimental effects of seizures on sociability, an effect localized to VTA glutamatergic neurons in which Cbln1 repression has a major role. Notably, restoring CBLN1 expression in these neurons was sufficient to therapeutically rescue impaired sociability. Seizures also synergized with increased UBE3A in dopaminergic neurons, probably occurring through Cbln1-independent mechanisms 41, 42 . Overall, these findings establish that VTA glutamatergic neurons drive sociability, and implicate downregulations of Cbln1 within these neurons as a crucial convergence point in the pathogenesis of sociability deficits in a genetic form of autism with epilepsy comorbidity. 
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Article reSeArcH MethOdS Mice. The Harvard Medical Area Standing Committee on Animals and the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center approved all mouse protocols. Mice were housed at the Center for Life Sciences barrier animal facility in sex-matched groups of 3-5 with ad libitum food (except for olfaction testing) and water access. Lights were on between 07:00 and 19:00 when behavioural testing/seizure induction was performed. Unless otherwise specified, littermate controls were used and cohorts were a mixture of male and female mice at a ratio of approximately 1:1. For experiments involving PTZ/ saline injections in wild-type mice (for example, Fig. 2a-c) , separate cohorts of wild-type FVB mice were bred within our colony. Ube3a transgenic mice were generated using bacterial artificial chromosome (BAC) recombineering techniques as described previously 4, 43, 44 . For Ube3a-NLS mice, three Flag tags were added to the C-terminal end of this construct, followed by two in-frame NLS from the SV40 large antigen, followed by two stop codons. For lox-TB-Ube3a mice, a loxP-flanked transcriptional blocker cassette (containing the En2 splice acceptor followed by a poly-A tail and a neomycin-resistance positive-selection marker 45 ) was introduced into intron 1 of the C-terminal triple-Flag-tagged Ube3a to block expression of all splice variants of Ube3a. For experiments in Fig. 3a -i and Extended Data Figs 7 and 8, lox-TB-Ube3a mice were bred to homozygosity. Since there is evidence that C-terminal extensions/modifications of UBE3A are detrimental to ubiquitin ligase activity against certain targets 32, 46 , we also generated Ube3a-1× (untagged) mice with a full-length Ube3a construct that is unmodified. BAC DNA was prepared using a Nucleobond BAC maxi-preparation kit (Clontech) and validated by sequencing analysis. Constructs were linearized and microinjected into FVB/ NJ embryos at the BIDMC Transgenic Core Facility. Male and female (tagged 4 or untagged) Ube3a-1× mice were crossed to result in wild-type, Ube3a-1× and Ube3a-2× mice. To determine transgenic Ube3a copy number, genomic DNA was isolated from mouse tail clips using the Purelink Genomic DNA Mini Kit (ThermoFisher). qPCR was performed to measure genomic copies of Ube3a and Tfrc using Taqman Mm00238405_cn probe (Ube3a) and Taqman Copy Number Reference Assay (Tfrc) with Taqman Genotyping Master Mix (ThermoFisher). Absolute Ube3a copy number was calculated using the 2 −ΔΔCt method and multiplying by a factor of two (two Tfrc alleles). This technique revealed the following approximate total copy numbers (that is, including the two native Ube3a copies): Ube3a-2× (7.8 ± 0.4, n = 4), lox-TB-Ube3a (8.97 ± 0.16, n = 5), Ube3a-2× untagged (5.13 ± 0.15, n = 8), Ube3a-NLS7 (3.59 ± 0.13, n = 6). Data are mean ± s.e.m.
Ube3a-mKO mice 5 (Jackson Labs) were backcrossed nine generations to FVB/ NJ before behavioural testing. Both p-Ube3a-mKO and m-Ube3a-mKO mice were generated based on the breeding scheme described in Fig. 1b . The following lines were bred into an FVB/NJ genetic background for six or more generations. Cbln1 fl/fl mice 17 were a gift from M. Mishina. VGLUT2-cre 47 mice and VGAT-cre mice 47 were a gift from B. Lowell. VGLUT2 fl/fl (ref. 48) , Emx-IRES-cre 49 , Math1-cre 50 , DAT-cre 51 , Dbh-cre 52 , Chat-cre 53 , ePet-cre 54 , and Ai32/ChR2-eYFP 55 lines of mice were purchased from Jackson Labs. Tissue. Brains were rapidly removed and submerged in ice-cold PBS for 20-30| s. For the isolation of cortex (microarray and validation studies), two slabs of total cortex were dissected using curved forceps. For tissue punches, the PBS-cooled brain was placed in a brain matrix (ASI Instruments), and razor blades were placed at 1-mm intervals to obtain brain slices. For hippocampal specimens, the entire hippocampal formation from one slice was carefully dissected so as to include all subfields. Punches were obtained with a 1-mm (retrosplenial cortex, cerebellum) or a 0.5-mm (rest) punch core needle (Harris Unicore; Extended Data Fig. 5a ) and immediately frozen at −20 °C and stored at −80 °C. RNA isolation, Affymetrix gene-chip hybridization, and qPCR. RNA was isolated using Trizol Reagent (Invitrogen) and column-purified using the RNAeasy Protect Mini Kit (Qiagen). First-strand cDNA synthesis was carried out with oligo-dTs and reverse transcriptase (Ambion). Microarray samples were hybridized to an Affymetrix GeneChip HT MG-430 PM array with tissue from six biological replicates of each genotype (wild type and Ube3a-2×) pooled into three pairs. Array normalization, expression value calculation and clustering analysis were performed using dChip software (http://www.dchip.org). We adjusted the statistical significance (nominal P value) of the entire gene set to account for multiple testing by estimating the FDR. While estimating FDRs, we used 50 random permutations to obtain a final list of 597 probes that satisfied our assumed significance threshold of 0.05. Primer pairs were selected through Primer3 (ref. 56 ) with specificity confirmed with Primer-BLAST 57 . Melt-curve analysis and agarose gel electrophoresis were used to confirm a single PCR product of the appropriate amplicon size. For microarray validation, three separate cDNA samples (each combined from two independent biological samples) were amplified through qRT-PCR in triplicate using Sybr (Life Technologies) or KAPA-Sybr (KAPA Biosystems) on a BioRad CFX384 Real Time Thermal Cycler. Gene expression fold changes were calculated with the comparative C t method 58 and normalized to Gapdh, with similar results obtained by normalizing to Rplp0 or Polr2a. Error bars for all qPCR experiments are an upper error limit that represents an s.e.m. for replicates from each sample, and were calculated as follows: ene of interest  2  reference gene  2  1 2  1 2 in which s.d. denotes standard deviation. Primer sequences are in Supplementary  Table 4 . Gene annotations and protein interactions. Regulated genes were annotated according to Gene Ontology (GO) categorization. P values for enrichment of each GO category were calculated using the Category, GOStats, and KEGGREST packages of Bioconductor 59,60 (Supplementary Table 2 ). In total, 598 up-and downregulated genes in Ube3a-2× mice as well as SFARI (Simons Foundation Autism Research Initiative) genes identified as strongly implicated in autism 12 were used to build an initial physical protein-protein interaction network by searching 7 current, high-quality, human-curated protein interaction networks (BioGRID, DIP (Database of Interacting Proteins), HPRD (Human Protein Reference Database), InnateDB, IntAct, MatrixDB, and MINT (Molecular Interaction Database)). We searched for and displayed clusters of interactions between protein products of pairs of UBE3A-regulated genes, UBE3A-regulated plus autism genes, or between autism genes. To reduce network complexity, gene nodes with edges connecting to a more select set of 276 SFARI genes with the strongest genetic evidence for a causal role in autism were included in the final network (Supplementary Table 3 ). We clustered and visualized the interactions using Cytoscape 3.2.0 and its GLay community clustering algorithm 61 . Subcellular fractionation and western blotting. Nuclear and cytosolic fractions of cortical samples (Extended Data Fig. 2d ) were separated using a commercially available reagent-based technique (Fisher Scientific) according to manufacturer instructions. Proteins were loaded onto 4-15% polyacrylamide gels (Bio-Rad), transferred to PVDF membranes, blocked with 5% non-fat milk in TBS and 0.1% Tween 20 (TBS-T), and incubated overnight at 4 °C with the following antibodies: anti-UBE3A (7526, Cell Signaling), anti-α-tubulin (3873, Cell Signaling), and anti-TATA-binding protein (TBP; 8515, Cell Signaling). After TBS-T washes, blots were incubated with species-specific horseradish peroxidase (HRP)conjugated secondary antibodies for 1-2 h at room temperature. Blots were developed with Pico chemiluminescent reagent (Pierce) and digital images were acquired using the gel dock system (Bio-Rad). After subcellular fractionation, nuclear and cytosolic UBE3A levels were normalized to levels of TBP and α-tubulin, respectively. Immunofluorescence. Mice were anaesthetized with an intraperitoneal injection of tribromoethanol and then perfused with ice-cold PBS followed by cold 4% paraformaldehyde. Brains were cryoprotected in 15% sucrose and then 30% sucrose (each for 24 h), and frozen in optical cutting temperature compound (Fisher Health Care). 16-μm sections were cut on a cryostat and slide-mounted. When an anti-mouse secondary antibody was used, sections were blocked with MOM reagent (Vector) and then with 10% normal goat serum with 1% BSA and 0.5% Triton X-100 in PBS and incubated at room temperature overnight with antibody Sections were washed and when required, incubated with Alexa-conjugated secondary antibodies (Invitrogen) for 3 h at room temperature, and then mounted in Vectashield with DAPI (Vector). Fluorescent images were taken using a LSM510 confocal microscope (Zeiss) or the VS120-SL 5 Slide Scanner (Olympus), and 'representative' images denote images from at least 3 mice per group. For quantitative immunofluorescence (Extended Data Fig. 2c ), cortex-containing sections of each genotype (Ube3a-NLS, Ube3a-1×, or Ube3a-2×) were placed on the same slide. Sections were stained as above with FITC-conjugated Flag primary antibody (Sigma). After incubation with primary antibody overnight, sections were mounted and imaged. Flag-FITC staining intensity was quantified from 3 mice per genotype. Quantification of nuclear protein was done using Image J and 20 randomly chosen cells identified using the DAPI stain were quantified per image; 3 images per mouse were examined. Neuropil staining was quantified in the same manner but regions devoid of DAPI staining were selected. Behavioural measurements. Mice were always tested at 7-11 weeks of age and were sexually naive. For experiments testing the effects of viral manipulations on behaviour, mice were randomly assigned into two groups matched for sex and age. For mice that received seizures (or saline injections), all testing was conducted 24 h after the last injection (or 30 days later). Before testing, mice were acclimatized to a dedicated behavioural suite for 1 h. Three-chamber testing was performed as
Article reSeArcH previously described 4 . A clear acrylic box (50 × 100 cm) containing dividers with 10 × 10 cm passageways was used to create a three-chambered arena. Ethovision video-tracking software (Noldus) was used with an overhead camera (Rainbow). Two small metal enclosures were placed in opposite corners (left or right). During the acclimation trial (5 min), mice were placed into the centre of the arena and allowed to explore freely, after which they were removed and placed into a holding cage. A new sex-and age-matched non-littermate wild-type mouse was placed in one of the two metal enclosures, with the side alternated between trials to cancel side bias. Then, during the social trial (5 min unless otherwise specified), the test mouse was reintroduced to the arena and allowed to explore freely. Between each mouse, the arena was wiped with Clidox-S. 'Sniffing times' were collected live during the social trial by a blinded observer trained to record the duration that a test mouse spends physically interacting/sniffing the 'social' or 'opposite' enclosures. Video-tracking was used to determine the total distance moved and chamber times (in left, middle and right chambers) during social and acclimation trials and was congruent with sniffing times (for example, Fig. 1d and Extended Data Fig. 2e ). Chamber times for the social trial for all three-chamber experiments are provided in Supplementary Table 5 . As described previously 22, 62 , sociability is either present/ intact or absent/impaired, and was formally defined as a significant preference to explore (or sniff) the social cue over the inanimate wire mesh cage by a post-hoc test following a two-way repeated measures ANOVA (see Statistics). In general, mice ambulated slightly shorter distances overall during the social trial (for example, Extended Data Fig. 2f ), although this was not always the case (for example, Extended Data Fig. 5c ). Ube3a-mKO mice ambulated shorter distances across both trials, consistent with previous reports of reduced locomotion 63 . Distances for both acclimation and social trials for all three-chamber experiments are provided in Supplementary Table 5 . For studies involving AAV2-DIO-hM3D(G q )-mCherry virus, approximately 28 days after AAV injections, mice received intraperitoneal injections of CNO (Sigma) dissolved in sterile saline 10 min before three-chamber testing. To demonstrate increased sociability in naive mice (that display preserved baseline sociability), an additional 5-min long social trial was performed immediately after the first. For open-field testing 4 , mice were placed into a 60 × 60 cm arena and freely explored for 10 min. Distance moved and the time spent in the centre (a concentric 40 × 40 cm square) was measured by video-tracking. For elevated plus maze testing (10 cm arm width, 30 cm wall elevation, 55 cm off the ground), mice freely explored for 10 min during which arm times and distances moved were measured by video-tracking. For ultrasonic vocalization measurements 4 , pairs of adult mice were placed into a clean plastic container within a sound-isolated box for 5 min while the number of USVs were measured using the using the condenser ultrasound microphone (AvisoftHBioacoustics CM16/CMPA) and the UltraSoundGate (Avisoft Bioacoustics 116Hb) connected to Avisoft Recorder USGH software (Avisoft Bioacoustics). When pairs of females were tested, both mice were of the same genotype/treatment group (for example, saline or PTZ) and age, but never cage-mates. When male-female pairs were tested, test males were paired with independently bred wild-type age-matched sexually mature female mice. In certain experiments, simultaneous video-recordings were collected and blindly scored offline to obtain the total time spent physically interacting. The buried food test was used to assay olfaction and was performed as described previously 64 . For two consecutive days before testing, mice were exposed to a single Teddy Graham (Nabisco) within their home cage. Then, 24 h before testing, all food was removed from their home cages. On the test day, mice were individually placed into a fresh cage filled with 3 cm of fresh bedding and a Teddy Graham buried in one randomly chosen corner. The time taken to find and begin to eat the Teddy Graham was recorded. For grooming measures, a blinded investigator live-scored the time spent grooming by a mouse placed into a fresh clean cage for 10 min (ref. 4). Rotarod testing was performed on an accelerating rotarod (Ugo Basile) designed to accelerate from 4 to 40 r.p.m. over 5 min. Mice were given three trials per day with a 60-min inter-trial interval for three consecutive days. Fall latencies were obtained through an automated trip detector plate underneath each mouse. When multiple behavioural tests were performed on a single cohort of mice, the following order was strictly obeyed: three-chamber sociability testing → ultrasonic vocalizations → grooming → open-field testing/elevated plus maze testing → buried food testing → rotarod testing. No more than one test was performed on any given day. PTZ-induced seizures. PTZ (Sigma) dissolved in 0.9% saline was injected intraperitoneally (10 ml kg −1 ). Mice were then placed individually into fresh cages and no more than three mice were simultaneously observed for 10 min by a trained blinded observer. Seizure severity was scored as previously described 65 . Mice received a score of '1' when they displayed hypoactivity, defined as a decline in motor activity until the animal came to rest in a crouched or prone position with the abdomen in full contact with the cage bottom. A score of '2' was assigned if the animal displayed at least one myoclonic jerk. Mice scored '3' when they displayed a generalized convulsion characterized by a sudden loss of upright posture with diffuse tonic posturing followed by clonic shaking. These episodes typically lasted between 20 and 40 s, after which a prolonged period of hypoactivity was observed, occasionally interspersed with a few myoclonic jerks. Mice rarely achieved a score of '4' , defined as a similar generalized tonic clonic seizure with notable hind limb extension. These maximal convulsions typically preceded death, which across all experiments, occurred at a rate of no more than 0-20% per cohort (typically 0%). Mice never displayed more than one convulsion during the observation period. This PTZ protocol did not significantly affect general well-being, as reflected by their unimpaired weight gain (Extended Data Fig. 6b ). Mice were assigned the 'highest' score they achieved (that is, a mouse that displayed hypoactivity together with myoclonic jerks scored 2, whereas a mouse that displayed myoclonic jerks that progressed to a generalized convulsion scored 3). While these scores are not continuous variables (and therefore strictly cannot be averaged), they nevertheless reflect a continuum of the behavioural responses to a PTZ injection. To provide a measure of the variability observed, the average scores from each day have been provided together with the s.e.m. Stereotaxic surgery and viral vectors. Anaesthesia was induced in a chamber with isofluorane/oxygen, after which mice were placed into a stereotaxic frame fitted with a continuous isofluorane delivery system. A single midline vertical scalp incision revealed skull landmarks. Stereotaxic measurements were used to make 0.5-mm wide burrholes over the entry point for bilateral viral injections directed at the VTA (0°, AP −3.3 mm, ML ±0.4 mm, DV −4.2 mm relative to bregma). 1 μl of virus was infused at 0.1 μl min −1 through a 33-gauge Hamilton needle connected to an automated infusion pump. After each infusion, the needle remained in place for 5 min. The incision was sutured closed and a single injection of 10 mg kg −1 meloxicam dissolved in saline was administered intraperitoneally for perioperative analgesia. All behavioural measurements were conducted approximately 20 days after surgery, following which accurate targeting to the VTA was confirmed by immunohistochemistry. Electrophysiological assays were conducted at least 30 days after the surgery during which VTA sections were also examined for accurate placement. AAV2-Cre-GFP, AAV2-GFP, AAV2-DIO-GFP, AAV2-DIO-hM3D(G q )-mCherry, and AAV2-EF1α-DIO-hChR2(E123T/T159C)-eYFP were purchased from the University of North Carolina Viral Vector Core. For AAV-hSYN-DIO-UBE3A, the coding sequence of human UBE3A isoform 3 was amplified by PCR from Plasmid 37605 (Addgene) using primers to add a SpeI site to the 5′ end and an AscI site to the 3′ end. The resulting product was then ligated into NheI and AscI sites of the pAAV-hSYN-DIO-eGFP vector, Plasmid 50457 (Addgene). For AAV-hSYN-DIO-CBLN1-IRES-mCherry, the coding sequence of mouse Cbln1 was amplified from cDNA clone MGC:66947 IMAGE:6404555 using primers to add an XbaI site to the 5′ end a BamHI site to the 3′ end and was then subcloned into the pLVX-IRES-mCherry vector (Clontech). An MluI site 3′ of mCherry was converted to an AscI site using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs). The Cbln1-IRES-mCherry cassette was digested with XbaI and AscI and subcloned into NheI and AscI sites of the pAAV-hSYN-DIO-eGFP vector. To generate AAV-VGLUT2-mCherry and AAV-VGLUT2-mCherry-2A-Cre, the coding sequence of mCherry or mCherry-2A-Cre was amplified from pLM-CMV-R-Cre Plasmid 27546 (Addgene) with primers to add a MluI and AscI site to the 5′ end and a HindIII site to the 3′ end and then were subcloned into MluI and HindIII of the pAAV-hSYN-DIO-eGFP vector. The 1.8-kb promoter region of mouse VGLUT2 was amplified from C57BL/6J whole-brain genomic DNA with primers 5′-TCTTCCACGCGTACGCACTCCCCTGGTTGATTTAG-3′ and 5′-TCTTCCGGCGCGCCTCTTGTAAAGACTGGTGTCCAGCCT-3′, digested with MluI (underlined) and AscI (underlined) and subcloned into pAAV-mCherry and pAAV-mCherry-2A-Cre. AAV9-hSYN-DIO-UBE3A and AAV2-hSYN-DIO-CBLN1-IRES-mCherry constructs were sent to the University of North Carolina Vector Core for viral particle production. AAV2/9-pVGLUT2-mCherry and AAV2/9-pVGLUT2-mCherry-2A-Cre constructs were sent to the Boston Children's Hospital Viral Core for viral particle production. Brain slice patch-clamp electrophysiology and in vitro optogenetics. Brains were rapidly removed and submerged in an ice-cold choline chloride replacement artificial cerebrospinal fluid (ACSF) containing (in mM): 126 choline chloride, 2.5 KCl, 1.2 NaH 2 PO 4 , 1.3 MgCl 2 , 8 MgSO 4 , 0.2 CaCl 2 , 20 glucose and 46 NaHCO 3 , equilibrated with 95% O 2 , 5% CO 2 . Coronal brain slices containing the nucleus accumbens (300-μm thick) were made using a Leica VT1200S microtome (Leica Microsystems). The slices were placed in a holding chamber containing ACSF comprising (in mM): 124 NaCl, 3 KCl, 1 MgSO 4 , 1.25 NaH 2 PO 4 , 2 CaCl 2 , 25 glucose and 26 NaHCO 3 , equilibrated with 95% O 2 , 5% CO 2 . The slices were maintained at 33 °C for 30 min and then kept at room temperature until studied. To increase the viability of neurons in the slices, 5 μM glutathione, 500 μM pyruvate, and 250 μM kynurenic acid were added to the choline chloride replacement ACSF and ACSF in the holding chamber in all experiments. During recording, slices were superfused (2 ml min −1 ) in ACSF without glutathione, pyruvate and kynurenic. Whole-cell recordings were performed from neurons located in the NAc shell under visual control on an upright microscope with differential interference contrast and infrared illumination. Patch pipettes were pulled using a P-97 puller (Sutter Instruments) and filled with (in mM): 130 K gluconate, 10 HEPES, 5 NaCl, 1 MgCl 2 , 0.02 EGTA, 2 MgATP, 0.5 NaGTP and 10 mM sodium phosphocreatine at a pH of 7.3 and osmolality of 275-290 mOsm. 1 mM Alexa Fluor 568 hydrazide was dissolved in internal solution and backfilled to the tip of the patch pipettes. Filled patch pipettes had resistances of 3-5 M. Synaptic currents were recorded in voltage clamp mode by an Axon MultiClamp 700B amplifier (Molecular Devices). Data were filtered at 1 kHz, digitized at 10 kHz with DigiData 1440A interface (Molecular Devices) and acquired by Clampex 10.5. MSNs were identified by their morphology and hyperpolarized resting membrane potential. Series resistance was monitored with a 5 mV hyperpolarizing step (5 ms). Resting membrane potential and action potentials were recorded in current clamp mode with action potentials induced by injecting 200 ms of positive currents ranging from 40 to 400 pA. An optical fibre (200 μm core diameter, 0.2 numerical apertures) was used to deliver optical stimulation. The fibre was placed 200 μm from the site of recording and coupled to a diode-pumped 473 nm laser (CrystaLaser Company) with stimulus intensity controlled from 1 to 30 mW. Light-pulse duration (5 ms) was controlled by a Master-8 stimulator and light-pulse frequency (0.1 Hz) was determined and triggered by the Clampex 10.5. Light intensities of 0, 1, 5 and 30 mW were used for input/output experiments with six sweeps collected for each. 30 mW laser light was used for maximal stimulation and pharmacology experiments, 12 consecutive sweeps were averaged with Clampfit 10.5 to determine the light-evoked EPSC amplitude. 30 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) was used in some studies to block and confirm AMPA receptor currents. Spontaneous EPSCs were recorded at a holding potential of −85 mV in the presence of GABA A antagonist bicuculline (10 μM). Spontaneous EPSCs were detected and analysed using Mini Analysis Program (Synaptosoft). Amplitude and area thresholds were set to 5 pA and 20 fC, respectively. The peak amplitude and inter-event interval of spontaneous EPSCs from 60-s episodes were used to generate cumulative probability plots, and the statistical significance was determined by Kolmogorov-Smirnov test. Statistics. Sample sizes are shown in the figures or legends and were chosen to meet or exceed sample sizes typically used in similar mouse behavioural experiments. For three-chamber sociability experiments, sniffing time measures were entered into a two-way repeated measures ANOVA. F statistics and P values for interaction effects between chamber side (social versus opposite) or experimental group (various viruses, treatments or genotypes) and main effects are presented in Supplementary Table 5 . When a significant main effect in either factor was detected (regardless of the presence of a statistical interaction), a Bonferroni post-hoc test was used to obtain a P value (adjusted for multiple comparisons) comparing the means of sniffing times for social and opposite conditions across groups 22, 62 . Thus, asterisk designations for all figures measuring three-chamber sociability represent the results of post-hoc comparisons. For experiments involving lox-TB-Ube3a mice exclusively ( Fig. 3a-i, Extended Data Fig. 8 ), the Holm-Sidak post-hoc test was used. For all other experiments, an unpaired two-tailed Student's t-test was used to compare two groups, and a two-way ANOVA was used to compare means across two or more dependent variables. A two-way repeated measures ANOVA was used for rotarod testing (Extended Data Fig. 5k ). Unless otherwise specified, data are presented as mean ± s.e.m. P < 0.05 was considered statistically significant. WNT1   CDH9  SCN1A  FOXG1   CDH8  ESR2   TBL1XR1   EP300   MBD6   PCP2   PTGS2  SYNE1  APC  CTNNB1  NCKAP5L   KAT2B  RPL10  CDH10   CDH15  ESR1  MBD5   SETDB1   NCKAP5   FLT1   STK39   JMJD1C   CDH11   NEK2  PXN   EXPH5   FER   MED12   PTEN   FRK   NEUROD1   TYR   GFRA2   EP400   CTCF   CHD7   TBC1D4   CHD8   ESRRB   TOP3B  SMARCD2  JARID2  CTBP2   EHMT1   ATRX   AR  TDO2   ANXA1   UBE3A   TBL1X   TCF4   MYLK   EIF4E   THRA   CITED2   HOXB1  EBF1  DACH1  MEIS1   WNT2 MEF2C NSD1   RORA   CAMK4   MECP2   XPC   HDAC4   HTR3C   BCOR   MTF1  MAFB   TRIP12   CREBBP   ITGA4   SND1   Cluster 1   HOMER1   STXBP1   GRM5   HOMER2   ADORA2A   HOMER3  PRKCB  GRM1   GNAS   PAX6   SYNGAP1   PLCB4   MAP2   GRIN2B   FABP5   CLSTN3  ITGB7   DOC2B   APBA2   GRASP   SYTL4   AFF2   NRXN3   SYT9   NRXN1   CBLN1   SYT6   EML1   NXPH1   CBLN3   MYO16   SYT2   GRID1   PTPRT   1190002N15RIK  PDZRN3   FAT2  GRID2   NLGN4X   NLGN3  NLGN1   DLGAP2  SSTR2   GRIK2   GRIN2A  INADL   SHANK3  SHANK1   SHANK2   CDKL5   KCNJ10   KCNJ2   GRIN2C   DLGAP3   IL16   CNKSR3   KCNA4   AKAP5   PRKG2   IQSEC2   ALDH5A1   SDK2   DLG4   MAOB   BAIAP2 
Extended Data Figure 2 | Ube3a-NLS mice and mice with increased untagged UBE3A levels display impaired sociability. a, Total UBE3A protein levels by western blot in wild-type, Ube3a-1×, Ube3a-NLS3 and Ube3a-NLS7 mice (F [3, 17] = 12.30, P < 0.001, 5 females per group). b, Flag staining in Ube3a-1× and Ube3a-NLS mice, counterstained with DAPI (somatosensory cortex; 3 females per genotype). Scale bar, 50 μm. c, Quantified nuclear and neuropil Flag immunofluorescence in arbitrary units (a.u.). d, UBE3A protein levels in cytosolic and nuclear fractions obtained from wild-type and Ube3a-NLS7 mice (4 females per group), demonstrating a selective increase in nuclear UBE3A protein levels (see Supplementary Fig. 1 ). TBP, TATA-box binding protein. e, Chamber times (for Fig. 1d ) during the social trial showing absolute times spent in social, middle and opposite chambers. f, Distances moved during acclimation/social trials analysed by two-way ANOVA: WT/Ube3a-1× (trial factor F [1, 56] = 18.09, P < 0.001, genotype factor F [1, 56] = 0.73, P > 0.1), WT/Ube3a-2× (trial factor F [1, 52] = 12.2, P < 0.001, genotype factor F [1, 52] = 2.046, P > 0.1), WT/Ube3a-2× untagged (trial factor F [1, 50] = 12.21, P < 0.01, genotype factor F[1,50] = 9.67, P < 0.01), WT/Ube3a-NLS3 (trial factor F [1, 56] = 14.41, P < 0.001), genotype factor F [1, 56] = 0.53, P > 0.1), WT/Ube3a-NLS7 (trial factor F [1, 56] = 22.68, P < 0.001, genotype factor F[1,56] = 4.88, P < 0.05), WT/p-Ube3a-mKO (trial factor F [1, 62] = 3.67, P > 0.05, genotype factor F [1, 62] = 216.7, P < 0.0001), WT/m-Ube3a-mKO (trial factor F [1, 48] = 1.75, P > 0.1, genotype factor F [1, 48] = 197.9, P < 0.001). g, Total time spent physically interacting during genotype-matched paired female interactions (for Fig. 1e ). h, Time spent self-grooming by female mice during a 10-min observation session across Ube3a-1× (n = 10 versus n = 14 WT), Ube3a-2× (n = 11 versus n = 12 WT), Ube3a-NLS3 (n = 14 per group) and Ube3a-NLS7 (n = 14 per group) mice. i, Ube3a-NLS7 (n = 15) and wildtype (n = 12) littermates take similar times to find a food item buried in fresh bedding. 
Extended Data Figure 5 | Characterization of VGLUT2-cre;Cbln1 fl/fl mice. a, Representative coronal sections from the Allen Mouse Brain Atlas 66 , with shaded red regions depicting the approximate geometric centre of punch biopsy samples used for qPCR experiments. Image credit: Allen Institute for Brain Science. b, Chamber times (for Fig. 1g ) during the social trial showing absolute time spent in social, middle and opposite chambers. c, Distances moved during acclimation/social trials analysed by two-way ANOVA (trial factor F [1, 32] = 27.21, P < 0.0001, genotype factor F [1, 32] 
Extended Data Figure 6 | Recurrent seizures induced by PTZ impair sociability. a, Ten daily 30 mg kg −1 PTZ injections applied to male wildtype mice resulted in a gradual daily increase in the percentage of animals that displayed a PTZ-induced generalized convulsion (n = 25). b, Weight change for PTZ-(n = 10) or saline-(n = 8) treated mice, with test day factor analysed by two-way repeated measures ANOVA (F[9,160] = 0.28, P > 0.1, treatment factor F [1, 160] = 0.34, P > 0.1). c, d, 24 h after the last PTZ (n = 16) or saline (n = 14) injection, open-field testing identified no significant differences in the time spent in the centre of the field (c) or the total distance ambulated in the field (d) (n = 10 per group). e, f, Similarly, on the elevated plus maze, 10 PTZ-induced seizures did not affect the time spent in the open arms (e) or distance moved (f) (n = 10 per group). g, Distances moved during acclimation/social trials for male mice analysed by two-way ANOVA (for Fig. 2b, treatment factor F[1,32] = 0.38, P > 0.1, trial factor F [1, 32] = 0.06, P > 0.1). h, i, Female wild-type FVB mice exposed to an identical 10-day PTZ protocol (n = 10) demonstrated impaired sociability 24 h after the last injection compared with mice that received saline alone (n = 9) (h), whereas the distances moved during acclimation/social trials were not affected (treatment factor F[1,34] = 2.47, P > 0.1, trial factor F[1,34] = 1.79, P > 0.1) (i). j, k, Ten PTZ-induced seizures do not affect self-grooming rates (n = 10 females per group) (j) or performance on the buried food test (k) (males: saline n = 10, PTZ n = 7 per group, females: saline n = 7, PTZ n = 9 per group). l, m, 30 days after the last of 10 daily PTZ injections, male wild-type FVB mice continue to display impaired sociability (saline n = 10 per group, PTZ n = 7 per group) (l), as do daily PTZ-treated female mice (saline n = 6 per group, PTZ n = 7 per group) (m). n, Distances moved during acclimation/social trials for Fig. 2f , g, analysed by two-way ANOVA. WT/p-Ube3a-mKO (trial factor F[1,62] = 5.06, P < 0.05, genotype factor F [1, 62] = 209.2, P < 0.0001) and WT/m-Ube3a-mKO (trial factor F [1, 54] = 0.20, P > 0.1, genotype factor F [1, 54] = 56.06, P < 0.001). o, Distances moved for Fig. 2h (trial factor F[1.62] = 3.57, P > 0.05, group factor F[2,62] = 1.57, P > 0.05). p, Distances moved for Fig. 2i (trial factor F[1,62] = 13.29, P < 001, group factor F[2,62] = 2.43, P > 0.05). q, Ube3a mRNA measured in punches from wild-type FVB males treated with 10 daily injections of 30 mg kg −1 PTZ or saline (HPc, n = 8 per group, ECx and VTA: saline n = 10, PTZ n = 8). Data are mean ± s.e.m. ***P < 0.001. Two-tailed unpaired Student's t-tests are used for all comparisons unless otherwise specified. Fig. 3k (genotype factor F [1, 28] = 14.45, P < 0.001, trial factor F[1,28] = 5.16, P < 0.05). c, Distances moved for Fig. 3l (genotype factor F[1,28] = 1.267, P > 0.1, trial factor F[1,28] = 2.72, P > 0.1). d-f, Distances moved for Fig. 4a (virus factor F[1,34] = 2.81, P > 0.1, trial factor F[1,34] = 2.02, P > 0.1) (d), time spent in the centre (e), or total distance moved (f) in an open field for AAV-Cre-GFP-injected (n = 12) or AAV-GFP-injected (n = 8) Cbln1 fl/fl mice. g, Distances moved for Fig. 4b (virus factor F[1, 44] = 7.9, P < 0.01, trial factor F [1, 44] = 20.49, P < 0.001). h, Distances moved for Fig. 4c (genotype factor F [1, 26] = 0.22, P > 0.1, trial factor F [1, 26] = 5.86, P < 0.05). i, Cumulative frequency plots of spontaneous EPSC (sEPSC) amplitudes for Fig. 4d , e. j, Representative response of an MSN to injected currents (−20 to +280 pA). k, Average resting membrane potentials in the NAc medial shell in control mice (n = 23 neurons) and mice with VTAtargeted AAV-Cre-GFP-mediated deletions of Cbln1 (n = 22 neurons, P > 0.1). l, Laser intensity needed to induce EPSC currents in medial shell NAc MSNs from ChR2-eYFP mice with AAV-Cre-GFP infused into the VTA (n = 5 neurons). m, Distances moved for Fig. 4i (trial factor F [1, 36] = 9.45, P < 0.01, virus factor F [1, 36] = 8.49, P < 0.01). n, o, Time spent in the centre (n) and distances moved (o) during the open field test after AAV-Cre-GFP-mediated deletion of VGLUT2 in the VTA (n = 8). p, Distances moved for Fig. 4i (genotype factor F[1,36] = 1.15, P > 0.1, trial factor F[1,36] = 6.18, P < 0.1). Data are mean ± s.e.m. *P < 0.05. Twotailed unpaired Student's t-tests are used for all comparisons across two groups, whereas two-way ANOVA is used for all comparisons of distances moved. Kolmogorov-Smirnov test was used in i.
